home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  May 23, 2024
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 461 active entries

Cardionemica Medical Information Enterprise of Canada

PNA-K2: a recent find at SB Internet in Life Sciences
Port Coquitlam
Toll free: 16049419022

Phone: 16049458408
Fax: 16049419022
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it



Cardionemia has recently emerged with the definition of heart health in respect to healthy heart and blood vessel tissues and even the respiratory tract and lungs given the rise of heart disease and death from heart attack especially in middle aged women.



Red meat including wild game meat and "heart health" is to be studied further in terms of its public health epidemiology and incidience of heart conditions and morbidity. Further investigation with cardionemics in water hyacinth as e. g. can be used to find the facts of mechanisms with physiology, and most of all, metabolism based on nutritional biochemistry and genetic linkages using nutrigenomics. Certainly, heart health food such as fish, fresh fruits and vegetables and life-style habits with exercise, viz., aerobic heart, lung and blood vessels and muscles rate of use and still to be found endocrinological factors, play a role, together with abstenance from tobacco and alcohol. 



1. Interventive Care: For acute care on medical life support including emergency; chronic for ongoing serious enough conditions that need immediate care of attention to prevent any more progression of medical conditions and eventual morbidity.

2. Preventative Care: A priori care or attention to possible medical sucsceptabilities based on medical histories as outlined or specified to allay onset of diagnotics and its conditions requiring treatment. Certainly preventative advocacy and care leads to better prognosis or outlook for every medical patient out there and makes better quality experience in health treatment and save hospital beds and cost of treatment by medicine.



Carrying over the idea that our recently discovered and to be corroborated with in terms of medical evidence from studies when administered intravenously (IV) by injection to the blood of regulatorily and directly applied (DA) medical agents like PNA-B12 or our own hypothetical PNA-K2 (in reference to membrane or cell wall traversing carriers of common Vitamins) at Skye Blue as it would act cytoplasmically and/or directly past the eucaryotic nuclear membrane of:

1. Heart Muscles (vs. Fat tissue)

2. Blood Vessels (vs. Atherosclerotic plaques)  

3. Heart Muscular Function in respect to pumping blood

4. B. P. (blood pressure) to relax blood vessel walls and improve heart efficiency and/or to relieve function, viz. pulse indicating rate of pumping.

Tissues as physiological and functional determinants are of concern here. The larger picture using DA regulatory biochemical agents is metabolic, nutritional (i. e. inputs) and can be nutrigenomic in nature, endocrinological and physiological, of course. 


(c) D. A. Flores. 2024. Skye Blue (SB) Internet. Port Coquitlam, B. C. Canada V3B 1G3. 

Selected Categories:
Product Company   Service Company
- General
- Services
- Communications

Last update of this entry: February 22, 2024

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.